Italy to increase tobacco prices in 2023

Dec.27.2022
Italian tobacco products will face a price hike in 2023 due to tax changes, affecting cigarette and e-cigarette users.

Smokers in Italy received some bad news as tobacco products will experience a price hike in 2023. The reason for this is due to a revision included in the 2023 budget law, which aims to reshuffle consumption taxes between different products through changes in taxes.

 

As we mentioned earlier, tobacco product users can expect to see a hike in the prices of their vice in 2023. According to the latest developments, a provision increasing the specific consumption tax on cigarettes has been approved by the executive branch led by President Meloni in the 2023 Budget Act. Starting January 1st, 2023, each pack of cigarettes will see a price increase of €0.20 (approximately RMB 1.48), with varying degrees of increment depending on the brand.

 

But that's not all. In 2024, the increase in cigarette prices will continue, with an additional raise of 0.10 or 0.15 euros after the growth in 2023. In other words, starting in 2024, cigarettes may cost an extra 35 cents (about 2.24 yuan) per pack.

 

In 2023, the growth is not only targeted at cigarette users, but also affects those who use electronic cigarettes, such as heated tobacco. However, for this type of cigarette, the increase in price is relatively small, with non-nicotine cigarettes costing approximately 0.08 euros per milliliter (about 0.59 yuan), while nicotine-containing cigarettes will rise to 0.13 euros (about 0.96 yuan).

 

The government's recent estimate projects that Italy could collect at least 100 million euros annually as the price of cigarettes and tobacco is set to increase by 2023.

 

It has been announced that cigarettes and tobacco will increase in price in 2023, but what will their prices be in 2021, with the introduction of the euro? The official website of the State Monopoly Agency for Customs and Excise has released a list of cigarette prices, including all brands available to the public, updated as of November 24th of this year. We can see that in 2022, a pack of cigarettes will cost between 4.8 and 6 euros.

 

Considering the rise in cigarette and tobacco prices in 2023, lower-priced cigarette packs may need to cost 5 euros, while higher-priced packs could even cost 6.20 euros. But what were cigarette prices in 2001? At that time, MS cost 2.17 euros, Camel increased to 2.48 euros, and the most popular brand, Marlboro, was priced at 3 euros. In short, over the last 20 years, cigarette prices have increased by more than 2 euros.

 

Let's take a look at who will spend more money next year in Italy, as cigarettes and tobacco prices are set to increase in 2023.

 

According to data analysis from Epicentre ISS, we can estimate that Italian regions will spend more money on cigarette and tobacco packaging next year due to the Meloni government's plan to increase prices in 2023, based on a two-year period from 2020-2021.

 

In Italy, where do people smoke the most? Among the regions with the highest smoking rates, the top ranking is held by certain areas in central and southern Italy, particularly Abruzzo, Umbria, and Campania, but there are also significant numbers of smokers in Emilia-Romagna.

 

On the contrary, in 2023, the regions of Puglia, Marche, Calabria and Friuli-Venezia Giulia will be less affected by the increase in cigarette and tobacco prices.

 

Data from the Istituto Superiore di Sanità reveals that in Italy, 50% of the population does not smoke, while 24.5% have a habitual consumption of cigarettes.

 

With the awareness that cigarettes and tobacco will increase in price in 2023, let's take a look at how much revenue the country generates from cigarette sales. In this scenario, data from 2020 from the demographic analysis institution, Eurispes, reveal that the country collects approximately 14 billion euros yearly from cigarette sales.

 

However, it is important to note that if we consider the expenses borne by the country itself on an annual basis to support public health measures, prevent and treat diseases related to tobacco consumption, the net profit is actually half of this figure, approximately 7 billion euros.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
In an interview with Romanian marketing publication IQads, Marek Gębski, Director of Smoke-Free Products at Philip Morris Romania, said IQOS experience spaces are evolving from traditional retail locations into platforms for consumer engagement and brand connection. Through locations such as IQOS Boutique Victoriei, PMI aims to use design, culture and consumer experiences to strengthen communication with adult consumers about smoke-free products. The interview highlights how tobacco companies are expanding smoke-free strategies beyond products toward experiential marketing and consumer relationships.
Aug.11
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
2Firsts Data | China’s U.S. Vape Exports Have Yet to Regain Previous Growth Momentum in H1 2026, but Hardware Grew 15.2% and 6-Methyl Nicotine-Related Products Rose 234.7%
2Firsts Data | China’s U.S. Vape Exports Have Yet to Regain Previous Growth Momentum in H1 2026, but Hardware Grew 15.2% and 6-Methyl Nicotine-Related Products Rose 234.7%
China’s vape exports to the U.S. reached approximately $1.58 billion in the first half of 2026, remaining broadly stable from a year earlier but still below previous growth momentum. 2Firsts’ analysis of China Customs data shows that the U.S. market has not simply returned to its previous trajectory after the enforcement shock and inventory-driven swings of 2025. Instead, export momentum is shifting across product categories. Vaping devices and atomization hardware increased 15.2% year over year, while 6-methyl nicotine-related and other nicotine substitute products surged 234.7%. Meanwhile, traditional nicotine-containing vaping products continued to face pressure.
Jul.22
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07